PMC:7441788 / 17774-17980 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T102","span":{"begin":197,"end":205},"obj":"Disease"}],"attributes":[{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T104","span":{"begin":197,"end":205},"obj":"Species"}],"attributes":[{"id":"A104","pred":"ncbi_taxonomy_id","subj":"T104","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T133","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"644","span":{"begin":166,"end":174},"obj":"Species"},{"id":"672","span":{"begin":0,"end":3},"obj":"Chemical"},{"id":"673","span":{"begin":106,"end":109},"obj":"Chemical"},{"id":"711","span":{"begin":197,"end":205},"obj":"Disease"}],"attributes":[{"id":"A644","pred":"pubann:denotes","subj":"644","obj":"Tax:9606"},{"id":"A672","pred":"pubann:denotes","subj":"672","obj":"MESH:D006886"},{"id":"A673","pred":"pubann:denotes","subj":"673","obj":"MESH:D006886"},{"id":"A711","pred":"pubann:denotes","subj":"711","obj":"MESH:C000657245"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T118","span":{"begin":73,"end":80},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T119","span":{"begin":97,"end":104},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T95","span":{"begin":197,"end":205},"obj":"Disease"}],"attributes":[{"id":"A95","pred":"mondo_id","subj":"T95","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"644","span":{"begin":166,"end":174},"obj":"Species"},{"id":"672","span":{"begin":0,"end":3},"obj":"Chemical"},{"id":"673","span":{"begin":106,"end":109},"obj":"Chemical"},{"id":"711","span":{"begin":197,"end":205},"obj":"Disease"}],"attributes":[{"id":"A644","pred":"tao:has_database_id","subj":"644","obj":"Tax:9606"},{"id":"A672","pred":"tao:has_database_id","subj":"672","obj":"MESH:D006886"},{"id":"A673","pred":"tao:has_database_id","subj":"673","obj":"MESH:D006886"},{"id":"A711","pred":"tao:has_database_id","subj":"711","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T133","span":{"begin":0,"end":206},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"HCQ 1200 mg daily for 3 days, 800 mg daily for 2 weeks (mild to moderate disease)/3 weeks(severe disease) HCQ did not show additional benefits of vial elimination in patients with mild to moderate COVID-19."}